Additionally, growth curve assays, 5‐ethynyl‐2'deoxyuridine (EdU) incorporation assays, colony formation assays, and Transwell assays were conducted to evaluate the cellular proliferation, migration, and invasive capacity of breast cancer cells and to further verify the tumorigenic function of PRMT6 in vitro. The gene discussed is PRMT6; the disease is breast carcinoma.